Category: Prescription Drugs
North America Prescription Drugs
-
United States Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032
... market was valued at $2551.32 million in 2023 and is expected to reach a revenue of $4237.32 million by 2032. MARKET INSIGHTS The United States Alzheimer’s disease therapeutics & diagnostics industry is growing rapidly, escalated ... Read More
-
Brand Name Pharmaceutical Manufacturing in the US - Industry Market Research Report
... launches, with over 28 novel drugs approved in 2022 (latest data available). Given increasing price scrutiny, competition from generics, intensifying market competition among brand-name producers and rising research and development expenses, many manufacturers have shifted ... Read More
-
Veterinary Pain Management
... by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Pain Management Drugs, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$2.1 Billion ... Read More
-
2024-2029 Global Drugs of Abuse Testing Market for 12 Assays - US, Europe, Japan - 2024 Supplier Shares and 2024-2029 Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers
... This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . This new report from LeadingMarketResearch.com provides analysis of the global drug of abuse testing market, including emerging tests, ... Read More
-
Digital Pharmacy Market Size, Share, Trends, Industry Analysis Report: By Product, Drug Type, Platform (Application Based, and Web Based), and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) – Market Forecast, 2024–2032
... Market Forecast, 2024–2032 The digital pharmacy market size is expected to reach USD 483.53 billion by 2032, according to a new study by Polaris Market Research. The report “Digital Pharmacy Market Size, Share, Trends, Industry ... Read More
-
Pharmaceuticals in the US: ISIC 2423
... ISIC 2423 market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of ... Read More
-
North America Dry Eye Disease Market Forecast 2024-2032
... valued at $2283.72 million in 2032, reaching a projected revenue of $3604.57 million by 2032. MARKET INSIGHTS The rising geriatric population in North America is a significant factor contributing to the growing number of cases ... Read More
-
Swine Health
... at a CAGR of 5.8% over the analysis period 2023-2030. Antibiotics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$2.5 Billion by the end of the ... Read More
-
Healthcare Consultants in the US - Industry Market Research Report
... manage risk. Over the five years to 2023, demand for healthcare consultants has increased because of technological advances in healthcare-related industries and the changing regulatory environment. Moreover, the 2010 Patient Protection and Affordable Care Act ... Read More
-
Cannabis Production in Canada - Industry Market Research Report
... Canada opened up medicinal cannabis production to more players in 2013, producers have grown continuously as they invest in production capabilities to produce quality products. As consumers shifted from illegal cannabis purchases to the licensed ... Read More
-
Pharmaceuticals North America (NAFTA) Industry Guide 2019-2028
... descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights The North American Free Trade Agreement (NAFTA) is a trade agreement between the countries in North ... Read More
-
Cough, Cold and Allergy (Hay Fever) Remedies in the US
... normalisation after the extreme double-digit growth brought about by the “tripledemic” in 2022. While most paediatric and adult cough and cold categories are expected to see slight negative growth in 2024, overall decline is mainly ... Read More
-
Pharmaceuticals in Canada
... players including key financial metrics and analysis of competitive pressures within the market. Key Highlights The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer ... Read More
-
Pharmaceuticals in North America
... players including key financial metrics and analysis of competitive pressures within the market. Key Highlights The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer ... Read More
-
Compounding Pharmacies in the US - Industry Market Research Report
... the broader Healthcare and Social Assistance sector. Compounded medications can address patients' noncompliance with their medication by offering tastes, routes of administration and dosages that are not otherwise commercially available. The aging population has stimulated ... Read More
-
Contract Research Organizations in the US - Industry Market Research Report
... for Food and Drug Administration (FDA) approval. An explosion in research and development investment, frustratingly high clinical trial costs and an uptick in patent expirations have driven pharmaceutical companies to outsource clinical trial management. These ... Read More
-
Medication Management Systems
... by 2030, growing at a CAGR of 9.9% over the analysis period 2023-2030. Inventory Management Solutions, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$2.2 Billion ... Read More
-
Sleeping Aids
... at a CAGR of 5.3% over the analysis period 2023-2030. Sleep Apnea Devices, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$36.9 Billion by the end ... Read More
-
Mild Cognitive Impairment Market Research Report By Disease Type (Amnestic MCI and Non-Amnestic MCI), By Age (Child, Adult, Geriatric), By Indication (Lewy Body Dementia, Parkinson’s Disease Dementia, Alzheimer’s Disease, Vascular Dementia, and Others) By Treatment (Medication (Cholinesterase Inhibitors, Benzodiazepines, Glutamate Inhibitors, Antihistamines, Mao Inhibitors, Proton Pump Inhibitors, and Others), Therapy (Cognitive Stimulation Therapy, Cognitive Behavioural Therapy (CBT)), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World – Industry Forecast Till 2032
... (Medication (Cholinesterase Inhibitors, Benzodiazepines, Glutamate Inhibitors, Antihistamines, Mao Inhibitors, Proton Pump Inhibitors, and Others), Therapy (Cognitive Stimulation Therapy, Cognitive Behavioural Therapy (CBT)), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World – ... Read More
-
Pharmacy Market in Us 2024-2028
... market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Animal Health Market In North America 2024-2028
... report on the animal health market in North America provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Multiple Myeloma Therapeutics
... by 2030, growing at a CAGR of 14.6% over the analysis period 2023-2030. Chemotherapy & Other Drugs, one of the segments analyzed in the report, is expected to record a 15.4% CAGR and reach US$37.6 ... Read More
-
United States Pain Management Therapeutics Market and Forecast Therapeutics (Devices and Pharmaceuticals), Pain Type, Drug Class, Indication, Distribution Channel and Company Analysis 2024-2032
... Therapeutics Market will reach US$ 36.15 billion by 2032, up from US$ 26.18 billion in 2023, with a CAGR of 3.65% between 2024 and 2032. Many factors are driving the market's rapid expansion such as ... Read More
-
US Oral Antiviral Market Size study, by Indication (Hepatitis, Human Immunodeficiency Virus (HIV), Influenza, Others) by Drug Class (Protease inhibitors, Reverse transcriptase inhibitors, Others) by Distribution Channel (Hospital pharmacies, Drug store and retail pharmacies, Online providers) Forecasts 2022-2032
... providers) Forecasts 2022-2032 US Oral Antiviral Market is valued approximately USD 9.98 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 1.69% over the forecast period 2024-2032. Oral ... Read More
-
US Neuroblastoma Drugs Market Size study, by Type (Chemotherapy, Immunotherapy, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Online, Offline), Forecasts 2022-2032
... 2023 and is anticipated to grow with a healthy growth rate of more than 7.11% over the forecast period 2024-2032. Neuroblastoma is a cancer primarily occurring in young children under five years old, originating in ... Read More
Research Assistance
